Looking ahead, 2009 will be a year of
many activities at Clinuvel. We have
been preparing various corporate
activities surrounding the development
of afamelanotide which we will able to
reveal by Q1.
We wish you, in anticipation of the
newsflow on the company, a healthy
and prosperous 2009.
Philippe Wolgen, MBA, MD
CEO
- Forums
- ASX - By Stock
- jan 2009
Looking ahead, 2009 will be a year of many activities at...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.73 |
Change
-0.570(3.99%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
$14.21 | $14.25 | $13.70 | $1.202M | 86.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3001 | $13.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.73 | 205 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 136 | 13.710 |
9 | 3583 | 13.700 |
2 | 2225 | 13.690 |
6 | 2742 | 13.680 |
2 | 136 | 13.670 |
Price($) | Vol. | No. |
---|---|---|
13.730 | 214 | 4 |
13.740 | 78 | 3 |
13.750 | 99 | 1 |
13.760 | 35 | 1 |
13.770 | 35 | 1 |
Last trade - 10.51am 27/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |